MENU
NRXS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Neuraxis (NRXS) Ownership - Who owns Neuraxis?

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more

Profile

Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
50.49M
P/E Ratio
N/A
Total Cash
4.38M
Projected Growth
N/A
Total Debt
478.43K
Revenue
3.36M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.41
Total Debt/Equity
N/A
Revenue/Share
0.41 USD as % of share price

Fundamentals

NRXS
Capitalization
50.5M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
4.38M
Total Cash/Share
0.41
Total Debt
478K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.41%
Revenue
3.36M
ROE
N/A
Book Value
2.28M
P/B Ratio
22.12
Cash Flow
N/A
Earnings
-0.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9.89K
Current Ratio
1.58
Current Revenue Per Employee
38638.76
Dividends Per Share - Security
N/A
EBITDA
-7.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.30
Revenue To Assets
-240.65
Shares Held By Institutions
2.51M
Shares Outstanding - Current
10.7M
Total Liabilities
3.49M
Total Volume MTD
N/A
Value
N/A
Gain YTD
4.405
View a ticker or compare two or three
NRXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRXS showed earnings on November 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com